Boeing temporarily halts delivery of 787 Dreamliners over fuselage issue

Boeing temporarily halts delivery of 787 Dreamliners over fuselage issue


The exterior of a 787 Dreamliner at the Boeing manufacturing facility in North Charleston, on December 13, 2022. 

Logan Cyrus | AFP | Getty Images

Boeing has temporarily halted deliveries of its 787 Dreamliners so it can do additional analysis on a fuselage component, the Federal Aviation Administration told CNBC Thursday.

The company won’t be able to resume deliveries until they can show the FAA they solved the issue.

Boeing declined to comment. Shares of the company fell slightly in off-hours trading.

The planes, which are often used for long-haul international routes, have suffered several issues for several years. This is not the first time that deliveries were halted.

In May 2021, Boeing halted deliveries of the wide-body planes for the second time in less than a year after the FAA determined there were issues with the manufacturer’s method for evaluating the aircraft. The FAA said previously the issues were related to problems with incorrect spacing in some parts of the 787 aircraft, including the fuselage, which Boeing acknowledged was a problem in 2020, sparking a five-month stop on deliveries.

In August 2022, it delivered its first 787 Dreamliner to American Airlines, marking a milestone for the company because the planes are a key source of revenue.

A few months later, United Airlines said it was planning to buy 100 787 Dreamliners, with the option to buy 100 more, to replace some of its older stock.

The order was a major boost for Boeing, and the planes were slated to be delivered between 2024 and 2032, United said previously.

United’s CEO Scott Kirby has said it was easier to buy more Boeing 787s over rival Airbus’s competing A350 wide-body plane.

“In this world where we’re trying to bring on 2,500 pilots a year and grow the airline, introducing a new fleet type slows that down dramatically,” he said on a call with reporters. “And the truth is the 787 is a better replacement for the [767] because it’s smaller.”

Read the full statement from the FAA:

“Boeing temporarily halted deliveries of 787 Dreamliners after notifying the FAA that it is conducting additional analysis on a fuselage component. Deliveries will not resume until the FAA is satisfied that the issue has been addressed. The FAA is working with Boeing to determine any actions that might be required for recently delivered airplanes.”

–CNBC’s Phil Le Beau contributed to this report.



Source

AI will supercharge sports team valuations, says Arctos Partners’ Charles
Business

AI will supercharge sports team valuations, says Arctos Partners’ Charles

A version of this article appeared in CNBC’s Inside Alts newsletter, a guide to the fast-growing world of alternative investments, from private equity and private credit to hedge funds and venture capital. Sign up to receive future editions, straight to your inbox. The rise of artificial intelligence is likely to boost the valuations of sports teams and […]

Read More
Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18
Business

Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18

Disney has named Josh D’Amaro, chairman of Disney Experiences, as its next CEO, succeeding Bob Iger and clinching a closely watched succession race at the Mouse House. Investors, industry insiders and onlookers have long awaited the announcement of who will take over as the next leader of one of the most storied U.S. companies. The […]

Read More
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Business

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. Patients with obesity or who are overweight lost up to 12.3% of their weight compared with placebo at week 28 in […]

Read More